Home Insight Page 10

Top Stories in Insight

RI is the future of investing

Editorial

  • November 9, 2018 November 12, 2019
  • 00:01

Out of chaos, a strategy

With trade deals revised, the U.S. looks determined to remake the world’s trading system to isolate China

Sector must embrace reforms

Editorial

  • October 26, 2018 November 12, 2019
  • 00:01

Tories have much to learn

Maxime Bernier's comment that his former party seems to have lost its soul has some validity

Clients have spoken — and regulators should listen

IFIC’s recent Canadian Mutual Fund Investor Survey found that investors are very satisfied with their advisors and prefer to pay their fees indirectly

Disclosure is severely limited

Editorial

USMCA won’t end trade spats

The negotiations that wound up on Sept. 30 are likely to be only the first in a litany of disputes with Washington

Inviting damage to investor confidence

Editorial

  • By: IE Staff
  • September 21, 2018 November 12, 2019
  • 00:01

Harsh lessons for Trudeau

The Trans Mountain Pipeline decision and NAFTA negotiations may lead to major policy changes for Canada

The culture that led to the crisis

Editorial

  • August 24, 2018 November 12, 2019
  • 00:01

Populism is nothing new

Political branding - as practised by Donald Trump, Viktor Orbán and Doug Ford - is harming democracy

Solid proposal or empty promise?

Editorial

  • July 27, 2018 November 12, 2019
  • 00:01

Trade, or “governtainment”

There is more than a tit-for-tat trade war going on between China and the U.S. And Canada should be paying attention

Bare trust debacle makes fools of the law-abiding

Editorial: Last-minute policy reversals undermine an already fragile trust between tax authorities and the public

  • By: IE Staff
  • March 29, 2024 March 29, 2024
  • 12:38

Guardian Capital acquires majority of Ontario investment counselling firm

CEO Ken Rae sells his stake but stays on as key leader

Pharmacare a promise Trudeau might come to regret

The Liberals’ re-election prospects look promising thanks to the co-operation of Big Pharma

What investors can expect in 2025

Uncertain policy backdrop, divergence among central banks and risk of re-emerging inflation are forecast to shape the investing landscape

Help your client sell their beneficial interest in an estate

Here’s your helpful guide to advising clients on a complex estate sales process

It’s time to re-evaluate U.S. equities allocation

High valuations and market concentration are headwinds for future returns

Letter: A déjà vu moment for bank sales practices

New review must be approached with urgency, transparency and a commitment to meaningful action, writes Harvey Naglie

Letter: OSC’s proposed disgorgement provisions are unfair and inadequate

A better solution is to start a compensation fund, writes lawyer Joseph Groia 

Letter: A case for rethinking investor education

Behavioural design is no silver bullet, writes Harvey Naglie